Stay informed with the latest litigation news. Explore now

Patent opposition analysis in metabolic drugs industry

In the competitive field of metabolic drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in metabolic drugs technology and learn how to protect your intellectual property.

Get Comprehensive Patent Opposition Report for the metabolic drugs Industry

Gain strategic insights, uncover critical details, and make informed decisions with expert-backed analysis.

Get Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Sep 4, 2025
CompanyTotal Oppositions
NOVARTIS173
BOEHRINGER INGELHEIM93
NOVO NORDISK69
AMGEN41
NUTRICIA40
BRISTOL MYERS SQUIBB37
CELGENE35
NESTLE32
PFIZER29
F HOFFMANN LA ROCHE28

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the metabolic drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the metabolic drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Sep 4, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the metabolic drugs industry

Nutritional ProductVITAFLOJul 29, 2025MOLNIA
Conjugate Of Galnac And Saponin, Therapeutic Composition Comprising Said Conjugate And A Galnac-Oligonucleotide ConjugateSAPREMEJul 29, 2025STRAWMAN
Use Of Aminopyridine, In Particular Amirampridine, In The Treatment Of Virally Associated FatigueBHMEKEJul 29, 2025LANGE
Nutritional ProductVITAFLOJul 24, 2025NUTRICIA
Methods For Treating Intrapulmonary InfectionsMERCK SHARP & DOHMEJul 23, 2025ADALVO
Composition Containing A Yeast For Preventing Simple And/Or Recurring CystitisLESAFFRE ET COMPAGNIEJul 23, 2025BIOCODEX
Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAJul 23, 2025MERCK SHARP & DOHME UK
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 16, 2025TEVA PHARMACEUTICALS
Treatment Of Cancer By Manipulation Of Commensal MicrofloraTHE UNIVERSITY OF CHICAGOJul 16, 2025HGF
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 15, 2025MAIWALD

To stay ahead in the competitive metabolic drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the metabolic drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY22
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofCELGENE15
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA13
Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA11
Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS11
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA THERAPEUTICS10
Sep 14, 2022Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM10
Aug 21, 2019Rapamycin Derivative For Treating Pancreas CancerNOVARTIS10